ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

12,383Medicare Part D Prescriptions Filled, Including Refills
$1.1M Total Retail Price of All Prescriptions
411 Patients Receiving at Least One Drug in Part D
72%Patients 65 Years and Older
55% Subsidized Claims for Low-Income Patients

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume .

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category
HYDROCODONE-ACETAMINOPHEN 1,167 776 S3
OMEPRAZOLE 654 491
ZOLPIDEM TARTRATE 241 152
FUROSEMIDE 238 196
LEVOTHYROXINE SODIUM 236 176
SIMVASTATIN 216 165
LISINOPRIL 200 151
LOSARTAN POTASSIUM 196 154
AMLODIPINE BESYLATE 185 167
CARVEDILOL 172 121
NEXIUM 170 121
ZETIA 168 128
CRESTOR 155 115
POTASSIUM CHLORIDE 152 131
HYDROMORPHONE HCL 152 80 S2
CITALOPRAM HBR 141 87
PROMETHAZINE HCL 136 59 R
AZITHROMYCIN 134 89
OXYCODONE HCL 130 49 S2
CYMBALTA 126 73
GABAPENTIN 126 74
FENOFIBRATE 118 91
ATORVASTATIN CALCIUM 115 67
METFORMIN HCL 109 51
PROAIR HFA 104 56
VYTORIN 103 75
WARFARIN SODIUM 102 99
METOPROLOL TARTRATE 101 86
CLOPIDOGREL 100 73
RANITIDINE HCL 99 75
PANTOPRAZOLE SODIUM 97 69
GLIMEPIRIDE 93 46
LOSARTAN-HYDROCHLOROTHIAZIDE 93 71
NAMENDA 89 79
ADVAIR DISKUS 87 46
PRAVASTATIN SODIUM 86 65
PLAVIX 82 67
METFORMIN HCL ER 81 59
SINGULAIR 79 56
POLYETHYLENE GLYCOL 3350 71 57
PEN NEEDLE 71 27
TRAZODONE HCL 70 47
LANTUS SOLOSTAR 70 31
METHADONE HCL 69 27 S2
FENTANYL 68 45 S2
ESTRADIOL 66 37 R
AMOXICILLIN 65 46
METOCLOPRAMIDE HCL 65 52
SERTRALINE HCL 65 37
FLUTICASONE PROPIONATE 63 47
CYCLOBENZAPRINE HCL 63 31 R
CIPROFLOXACIN HCL 62 48
PREDNISONE 59 49
TOPIRAMATE 59 20
TRAMADOL HCL 58 39
BYSTOLIC 57 34
DOXYCYCLINE HYCLATE 57 42
ABILIFY 57 23
AMITRIPTYLINE HCL 56 23 R
SPIRONOLACTONE 54 44
SPIRIVA 54 25
TRICOR 53 26
ZOSTAVAX 53 47
LANTUS 53 47
MONTELUKAST SODIUM 52 36
FINASTERIDE 50 50
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.